Getinge (OTCMKTS:GNGBY) Shares Gap Up – What’s Next?

Getinge (OTCMKTS:GNGBY) shares gapped up before the market opened on Friday . The stock had previously closed at $21.53, but opened at $24.18. Getinge shares last traded at $24.18, with a volume of 107 shares changing hands.

Analyst Ratings Changes

Separately, Zacks Research raised Getinge to a “hold” rating in a report on Thursday, April 23rd. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy”.

Getinge Stock Performance

The business’s fifty day moving average is $20.65 and its two-hundred day moving average is $21.34. The company has a quick ratio of 0.86, a current ratio of 1.32 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $6.59 billion, a PE ratio of 23.03 and a beta of 0.96.

Getinge (OTCMKTS:GNGBY) last announced its quarterly earnings results on Friday, July 17th. The company reported $0.38 earnings per share for the quarter. The company had revenue of $894.87 million for the quarter. Getinge had a net margin of 6.92% and a return on equity of 10.39%. As a group, research analysts anticipate that Getinge will post 1.33 EPS for the current fiscal year.

Getinge Company Profile

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.